Cargando…
Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas
BACKGROUND: Classifiers based on molecular criteria such as gene expression signatures have been developed to distinguish Burkitt lymphoma and diffuse large B cell lymphoma, which help to explore the intermediate cases where traditional diagnosis is difficult. Transfer of these research classifiers...
Autores principales: | Sha, Chulin, Barrans, Sharon, Care, Matthew A., Cunningham, David, Tooze, Reuben M., Jack, Andrew, Westhead, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512160/ https://www.ncbi.nlm.nih.gov/pubmed/26207141 http://dx.doi.org/10.1186/s13073-015-0187-6 |
Ejemplares similares
-
A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma
por: Care, Matthew A., et al.
Publicado: (2013) -
SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity
por: Care, Matthew A., et al.
Publicado: (2014) -
Gene expression meta-analysis reveals immune response convergence on the IFNγ-STAT1-IRF1 axis and adaptive immune resistance mechanisms in lymphoma
por: Care, Matthew A., et al.
Publicado: (2015) -
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
por: Davies, Andrew, et al.
Publicado: (2019) -
Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer
por: Care, Matthew A., et al.
Publicado: (2019)